CSS
FBIO icon

Cubist Systematic Strategies’s Fortress Biotech FBIO Stock Holding History

Cubist Systematic Strategies’s Portfolio FBIO Stock Details FBIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		$77.3K Buy
+20,933
New +$52.9K ﹤0.01% 2805
2021
Q2 		– Sell
-778
Closed -$41K – 2965
2021
Q1 		$41K Buy
+778
New +$43.9K ﹤0.01% 2744

Other funds holding FBIO

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SF
Summit Financial Parsippany, New Jersey $9.12B AUM 27.44% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return
SAM
Shikiar Asset Management New York $396M AUM 41.06% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
SC
Sculptor Capital New York $12.3B AUM 40.25% 1-Year Est. Return
KAS
Kestra Advisory Services Austin, Texas $31B AUM 28.39% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
HWM
HB Wealth Management Atlanta, Georgia $17.8B AUM 24.16% 1-Year Est. Return

Cubist Systematic Strategies's FBIO Position: Q3 2025 in Review

Cubist Systematic Strategies opened a new position in Fortress Biotech (FBIO) in Q3 2025: 20,933 shares worth $77.3K. The stake represents ﹤0.01% of the portfolio and ranks #2805 among its holdings. This is a return to the name: Cubist Systematic Strategies previously reported a position in FBIO as recently as Q1 2021.

Cubist Systematic Strategies first reported a position in FBIO in Q1 2021 and has held it in 2 quarters since. 56 funds tracked by Wall St. Rank hold FBIO as of Q3 2025.

  • Cubist Systematic Strategies held 20,933 shares of Fortress Biotech worth $77.3K as of Q3 2025.
  • Fortress Biotech was a new Cubist Systematic Strategies position in Q3 2025.
  • Fortress Biotech made up ﹤0.01% of Cubist Systematic Strategies's portfolio in Q3 2025, its #2805 holding.
  • Cubist Systematic Strategies first reported a position in Fortress Biotech in Q1 2021 and has held it in 2 quarters since.
  • 56 funds tracked by Wall St. Rank held Fortress Biotech as of Q3 2025.

Based on Cubist Systematic Strategies's 13F filing for Q3 2025, filed 14 Nov 2025.